NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
18.57
-0.43 (-2.26%)
At close: Feb 21, 2025, 4:00 PM
18.55
-0.02 (-0.11%)
After-hours: Feb 21, 2025, 5:48 PM EST
NAMS Market Cap
NAMS has a market cap or net worth of $1.99 billion as of February 21, 2025. Its market cap has increased by 20.74% in one year.
Market Cap
1.99B
Enterprise Value
1.57B
1-Year Change
20.74%
Ranking
Category
Stock Price
$18.57
Market Cap Chart
Since February 8, 2021, NAMS's market cap has increased from $154.45M to $1.99B, an increase of 1,187.14%. That is a compound annual growth rate of 88.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 1.99B | -27.74% |
| Dec 31, 2024 | 2.75B | 199.19% |
| Dec 29, 2023 | 919.56M | 3.44% |
| Dec 30, 2022 | 889.00M | 537.58% |
| Dec 31, 2021 | 139.43M | -9.72% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |